1652130 - Intellia Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - NTLA (1652130)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
22 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S2+1+2-3+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-07-16
NTLAFormela Jean FrancoisDirS - Sale$31.17-6,6861,615,3210%-$208,397
2018-06-19
NTLAFormela Jean FrancoisDirS - Sale$27.96-6,6861,836,8100%-$186,908
2018-05-16
NTLAFormela Jean FrancoisDirS - Sale$25.04-6,6862,058,2990%-$167,389
2018-05-14
NTLALeonard John M.Pres, CEOS - Sale$24.00-8,400525,767-2%-$201,600
D
2018-03-28
NTLABell GraemeEVP, CFOM - OptEx$13.48+8,00021,400+60%+$107,840
2018-03-23
NTLADorsa CarolineDirA - Grant$24.05+4105,410+8%+$9,861
2018-03-20
NTLAFormela Jean FrancoisDirS - Sale$23.87-39,2452,279,788-2%-$936,743
2018-01-29
NTLACaribou Biosciences, Inc.10%S - Sale$26.78-550,6453,994,355-12%-$14,746,273
2017-12-12
NTLANovartis Institutes For Biomedical Research, Inc.10%S - Sale$18.30-1,523,0004,129,903-27%-$27,870,900
M
2017-12-06
NTLABermingham NessanPres, CEOS - Sale$20.79-336,783458,250-42%-$7,000,019
2017-11-03
NTLABell GraemeEVP, CFOA - Grant$22.04+5,00013,400+60%+$110,217
2017-09-13
NTLACaribou Biosciences, Inc.10%S - Sale$0.00-1,048,8464,545,000-19%-$0
M
2017-07-07
NTLAFormela Jean FrancoisDirS - Sale$16.24-150,0003,579,788-4%-$2,435,440
M
2017-07-07
NTLAAtlas Venture Fund Ix, L.P.10%S - Sale$16.24-150,0003,579,788-4%-$2,435,440
2017-06-02
NTLADorsa CarolineDirA - Grant$12.42+5,0005,000New+$62,100
2017-06-01
NTLAKarsen Perry ADirA - Grant$11.98+5,0005,000New+$59,925
2017-06-02
NTLABell GraemeEVP, CFOA - Grant$12.37+8,4008,400New+$103,938
2017-06-01
NTLARivera Jose EEVP, GC, OpsA - Grant$12.03+8,400271,204+3%+$101,075
2017-06-01
NTLALeonard John M.EVP, R, DA - Grant$12.06+8,400533,223+2%+$101,322
2017-06-01
NTLABermingham NessanPres, CEOA - Grant$11.95+8,400795,033+1%+$100,379
M
2017-03-09
NTLAAtlas Venture Associates Ix, L.P.10%S - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
M
2017-03-09
NTLAFormela Jean FrancoisDirS - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top